Apple, Biotech, and Rail Stocks Hit New Highs on Analyst Upgrades

Shares of Apple Inc., Q32 Bio, and CSX Corp. reached new 52-week highs on Monday after investors responded positively to various catalysts.

Citi raised its price target for Apple to $365 from $315, citing improved margin expectations following the company's recent product price increases.

Apple stock ended the session at a record high of $323.45, up 0.6% on the day.

Q32 Bio stock surged 90%, reaching a 19-month high of $22.50 after reporting encouraging Phase 2a trial results for its hair loss treatment bempikibart.

The company plans to pursue a registration-directed development program by the first half of 2027 and has announced a $200 million public stock offering to finance future clinical development.